Functional Status After Operation for Ebstein Anomaly. The Mayo Clinic Experience

Journal of the American College of Cardiology

Volumn 52, Issue 6, 2008, Pages 460-466

  Brown, Morgan L ^a   Dearani, Joseph A ^a   Danielson, Gordon K ^a   Cetta, Frank ^a   Connolly, Heidi M ^a   Warnes, Carole A ^a   Li, Zhuo ^a   Hodge, David O ^a   Driscoll, David J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Ebstein anomaly; heart defects congenital; surgery; valves

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE PHOSPHATE; DIURETIC AGENT; FUROSEMIDE; PROCAINAMIDE; QUINIDINE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VERAPAMIL; WARFARIN;

ADULT; AGED; ARTICLE; CONGENITAL HEART DISEASE; EBSTEIN ANOMALY; ENDOCARDITIS; EXERCISE TOLERANCE; FEMALE; FUNCTIONAL STATUS; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART SURGERY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; PREGNANCY; PRIORITY JOURNAL; RECURRENT DISEASE; REOPERATION; STROKE; SURVIVAL; SYMPTOM; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; CARDIAC SURGICAL PROCEDURES; CHILD; CHILD, PRESCHOOL; EBSTEIN ANOMALY; EXERCISE TOLERANCE; FEMALE; HEALTH STATUS; HEART VENTRICLES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MINNESOTA; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; TRICUSPID VALVE;

EID: 47849110857     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.03.064     Document Type: Article

References (12)

1. Dearani J.A., O'Leary P.W., and Danielson G.K. Surgical treatment of Ebstein's malformation: state of the art in 2006. Cardiol Young 16 Suppl 3 (2006) 12-20
2. Brown M.L., Dearani J.A., Danielson G.K., et al. The long term outcome of operation for 539 patients with Ebstein's anomaly. J Thorac Cardiovasc Surg 135 (2008) 1120-1136 1136.e1-7
3. Anderson K.R., and Lie J.T. The right ventricular myocardium in Ebstein's anomaly: a morphometric histopathologic study. Mayo Clin Proc 54 (1979) 181-184
4. Khositseth A., Danielson G.K., Dearani J.A., Munger T.M., and Porter C.J. Supraventricular tachyarrhythmias in Ebstein's anomaly: management and outcome. J Thorac Cardiovasc Surg 128 (2004) 826-833
5. MacLellan-Tobert S.G., Driscoll D.J., Mottram C.D., Mahoney D.W., Wollan P.C., and Danielson G.K. Exercise tolerance in patients with Ebstein's anomaly. J Am Coll Cardiol 29 (1997) 1615-1622
6. Driscoll D.J., Mottram C., and Danielson G. Spectrum of exercise intolerance in 45 patients with Ebstein's anomaly and observations on exercise tolerance in patients after surgical repair. J Am Coll Cardiol 11 (1988) 831-836
7. Crenshaw C., and Coulam C. Clinical Obstetrics and Gynecology (1986), JB Lipppincott, Hagerstown, MD
8. Bierman J., Siegel E., French F., and Simonian K. Analysis of the outcome of all pregnancies in a community: Kavai pregnancy study. Am J Obstet Gynecol 91 (1965) 38-45
9. Driscoll D.J., Michels V.V., Gersony W.M., et al. Occurrence risk for congenital heart defects in relatives of patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation 87 (1993) I114-I120
10. Drenthen W., Pieper P.G., Roos-Hesselink J.W., et al., ZAHARA Investigators. Outcome of pregnancy in women with congential heart disease: a literature review. J Am Coll Cardiol 49 (2007) 2303-2311
11. Connolly H.M., and Warnes C.A. Ebstein's anomaly: outcome of pregnancy. J Am Coll Cardiol 23 (1994) 1194-1198
12. Dearani J.A., and Danielson G.K. Congenital Heart Surgery Nomenclature and Database Project: Ebstein's anomaly and tricuspid valve disease. Ann Thorac Surg 69 (2000) S106-S117